Candidiasis, Invasive Completed Phase 3 Trials for Caspofungin (DB00520)

Also known as: Invasive Candidiasis / Systemic moniliasis / Systemic candida / Disseminated candidiasis / Disseminated candida / Systemic candidiasis

IndicationStatusPhase
DBCOND0036184 (Candidiasis, Invasive)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00413218Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsTreatment
NCT00250432A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)Treatment